Susquehanna International Group
NERV icon

Susquehanna International Group’s Minerva Neurosciences NERV Stock Holding History

Susquehanna International Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$718K Buy
+119,131
New +$683K ﹤0.01% 8752
2024
Q4 		– Sell
-20,224
Closed -$54K – 12866
2024
Q3 		$54K Buy
20,224
+8,286
+69% +$24.1K ﹤0.01% 11353
2024
Q2 		$38.1K Sell
11,938
-4,743
-28% -$12.8K ﹤0.01% 11510
2024
Q1 		$43K Buy
+16,681
New +$102K ﹤0.01% 11611
2023
Q4 		– Sell
-10,804
Closed -$74.5K – 12971
2023
Q3 		$74.5K Buy
+10,804
New +$96.8K ﹤0.01% 11108
2022
Q2 		– Sell
-7,037
Closed -$28.8K – 13586
2022
Q1 		$47K Sell
7,037
-10,527
-60% -$64.6K ﹤0.01% 12336
2021
Q4 		$113K Sell
17,564
-6,591
-27% -$62.1K ﹤0.01% 12056
2021
Q3 		$336K Buy
24,155
+18,367
+317% +$276K ﹤0.01% 10332
2021
Q2 		$107K Buy
5,788
+2,792
+93% +$60.1K ﹤0.01% 12060
2021
Q1 		$70K Sell
2,996
-7,797
-72% -$195K ﹤0.01% 11969
2020
Q4 		$202K Buy
10,793
+782
+8% +$19.7K ﹤0.01% 10023
2020
Q3 		$255K Sell
10,011
-33,848
-77% -$915K ﹤0.01% 9028
2020
Q2 		$1.27M Buy
43,859
+12,524
+40% +$735K ﹤0.01% 5385
2020
Q1 		$1.51M Buy
31,335
+28,392
+965% +$1.71M ﹤0.01% 4487
2019
Q4 		$167K Sell
2,943
-219
-7% -$9.66K ﹤0.01% 8879
2019
Q3 		$196K Sell
3,162
-216
-6% -$12.2K ﹤0.01% 9111
2019
Q2 		$152K Buy
+3,378
New +$169K ﹤0.01% 9361
2017
Q3 		– Sell
-17,360
Closed -$996K – 9353
2017
Q2 		$1.23M Buy
+17,360
New +$1.12M ﹤0.01% 4841
2017
Q1 		– Sell
-6,338
Closed -$492K – 9614
2016
Q4 		$596K Buy
+6,338
New +$647K ﹤0.01% 6613
2016
Q2 		– Sell
-2,567
Closed -$126K – 9066
2016
Q1 		$126K Buy
+2,567
New +$110K ﹤0.01% 8321

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

Susquehanna International Group's NERV Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Minerva Neurosciences (NERV) in Q1 2026: 119,131 shares worth $718K. The stake represents ﹤0.01% of the portfolio and ranks #8752 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in NERV as recently as Q3 2024.

Susquehanna International Group first reported a position in NERV in Q1 2016 and has held it in 20 quarters since. The position peaked at $1.51M in Q1 2020. 47 funds tracked by Wall St. Rank hold NERV as of Q1 2026.

  • Susquehanna International Group held 119,131 shares of Minerva Neurosciences worth $718K as of Q1 2026.
  • Minerva Neurosciences was a new Susquehanna International Group position in Q1 2026.
  • Minerva Neurosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8752 holding.
  • Susquehanna International Group first reported a position in Minerva Neurosciences in Q1 2016 and has held it in 20 quarters since.
  • Susquehanna International Group's Minerva Neurosciences position peaked at $1.51M in Q1 2020.
  • 47 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.